Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析

【英語タイトル】Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C9448)・商品コード:DATA904C9448
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Osiris Therapeutics Inc (OSIR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Osiris Therapeutics Inc (Osiris) is a regenerative medicine company. It researches, develops and markets regenerative medicine products. The company developed the world’s first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Nov 07,2018: Osiris Therapeutics reports third quarter 2018 results
Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 03,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
Oct 02,2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues
Jun 04,2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Osiris Therapeutics Inc – Key Facts 6
Osiris Therapeutics Inc – Key Employees 7
Osiris Therapeutics Inc – Key Employee Biographies 8
Osiris Therapeutics Inc – Major Products and Services 9
Osiris Therapeutics Inc – History 10
Osiris Therapeutics Inc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Osiris Therapeutics Inc – Business Description 15
Osiris Therapeutics Inc – Corporate Strategy 16
Osiris Therapeutics Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
Osiris Therapeutics Inc – Strengths 17
Osiris Therapeutics Inc – Weaknesses 18
Osiris Therapeutics Inc – Opportunities 19
Osiris Therapeutics Inc – Threats 20
Osiris Therapeutics Inc – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s, Lifesciences Financial Deals and Alliances 28
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Osiris Therapeutics Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results 31
Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 32
Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation 33
Oct 02, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues 34
Jun 04, 2018: Osiris Announces Implementation of Prestige Lyotechnology Preservation Method Allowing Ambient Storage of Living Tissues 35
Feb 06, 2018: Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO 36
Oct 23, 2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane 37
Oct 19, 2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology 38
Jun 26, 2017: Osiris Appoints Linda Palczuk to serve as its President & CEO 39
May 31, 2017: Osiris Appoints David White to its Board of Directors 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Osiris Therapeutics Inc, Key Facts 6
Osiris Therapeutics Inc, Key Employees 7
Osiris Therapeutics Inc, Key Employee Biographies 8
Osiris Therapeutics Inc, Major Products and Services 9
Osiris Therapeutics Inc, History 10
Osiris Therapeutics Inc, Subsidiaries 13
Osiris Therapeutics Inc, Key Competitors 21
Osiris Therapeutics Inc, Ratios based on current share price 22
Osiris Therapeutics Inc, Annual Ratios 23
Osiris Therapeutics Inc, Annual Ratios (Cont...1) 24
Osiris Therapeutics Inc, Interim Ratios 26
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Osiris Therapeutics Inc, Recent Deals Summary 30
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Osiris Therapeutics Inc, Performance Chart (2013 - 2017) 25
Osiris Therapeutics Inc, Ratio Charts 27
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

★調査レポート[Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析] (コード:DATA904C9448)販売に関する免責事項を必ずご確認ください。
★調査レポート[Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆